STN1 and melanoma: While the STN1-deficient male cohort showed a moderate increase in melanoma formation and the female STN1-deficient mice showed a reduction in melanoma formation, statistical analysis showed no significance of tumor incidences in male (p=0.539, two-sided Fisher exact tests) or female (p=0.206, two-sided Fisher exact tests) cohort between STN1-deficient mice and control animals (Figure 3G), probably due to the lower number of melanoma-positive animals.